Aquestive Therapeutics (AQST) Preferred Shares (2017)
Aquestive Therapeutics (AQST) recorded quarterly Preferred Shares of $16.9 million in Q4 2017.
Aquestive Therapeutics (AQST) Preferred Shares (2017) Analysis & Trends
Aquestive Therapeutics' Preferred Shares history runs 1 years deep, the most recent figure standing at $16.9 million for Q4 2017.
- In Q4 2017, Preferred Shares changed N/A year-over-year to $16.9 million; the TTM figure through Dec 2017 stood at $16.9 million (changed N/A YoY), while the FY2017 annual figure was $16.9 million, changed N/A from the prior year.
- Preferred Shares was $16.9 million for Q4 2017 at Aquestive Therapeutics.
- In the past five years, Preferred Shares ranged from a high of $16.9 million in Q4 2017 to a low of $16.9 million in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Aquestive Therapeutics | 480.63 Mn | 369.90 Mn | 10.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 16.89 Mn |